Nektar Therapeutics (NKTR)

68.11 -0.25 (-0.37%) USD  |  NASDAQ  |  Mar 03, 16:00
68.37 +0.26 (+0.38%) After-Hours: 18:41
More

Nektar Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade